New York, December 2021: Axiom Market Research & Consulting™ added a report on immunoglobulin market which includes study on product, mode of delivery, application, and geography. Immunoglobulin market was projected to grow at a CAGR of 7.27% for the forecast period 2021 to 2027. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the immunoglobulin market.
The factors such as increasing prevalence of the immunodeficiency diseases, along with increase in the adoption of the immunoglobulin propelling the demand for the market and the growing research and development activities for the advanced product innovation has been responsible for boosting the growth of the immunoglobulin market during the forecast period.
The report analyses the immunoglobulin market based on the product, application, mode of delivery, and geography. By product, the immunoglobulin market is segmented into IgG, IgA, IgM, IgE, and IgD. By mode of delivery, the immunoglobulin market is segmented into intravenous and subcutaneous. By application, the immunoglobulin market is segmented into chronic inflammatory demyelinating polyneuropathy (cidp), guillain?barre syndrome, hypogammaglobulinemia, idiopathic thrombocytopenic purpura (itp), immunodeficiency disease, inflammatory myopathies, multifocal motor neuropathy, myasthenia gravis, and specific antibody deficiency. Geographically, the immunoglobulin market is studied for the regions including North America, Europe, Asia Pacific, and Rest of the World.
The factors like potential for eliminating the infectious agent further so that the product can be ideally used for the patient once in a week or two weeks, and this is expected to contribute in the growth of the segment in the immunoglobulin market during the forecast period.
The factors such as increasing number of the product launches and the increasing adoption for the subcutaneous mode of delivery segment in the immunoglobulin market has been responsible for the growth of the market during the forecast period.
Because of the increasing deficiency of the selective IgG among the population, along with the increasing prevalence of the hypogammaglobulinemia disorder across the world, has been propelling the growth of the segment in the immunoglobulin market during the forecast period.
The factors such as increasing demand from the hospital and clinics for the treatment of the primary immunodeficiency disease in the patients, along with the increasing adoption and approval for the immunoglobulin has been contributing to the growth of the market in the region of North America.
The key players in the immunoglobulin market are ADMA Biologics, Inc, Baxter international Inc., Bayer Healthcare, Bio Products Laboratory, Biotest AG, China Biologics Products, Inc, CSL Ltd., Evolve Biologics Inc, GigaGen, Inc., Grifols S.A, Johnson & Johnson (Omrix Biopharmaceuticals, Inc), Kedrion Biopharma Inc., LFB group, Octapharma AG, Sanquin Plasma Products B.V., Shanghai RAAS Blood Products Co., Ltd, Shire (Baxalta) and Takeda Pharmaceutical Company Limited among others.
Browse for More Details: https://www.axiommrc.com/product/10580-immunoglobulin-market-report
3 Germay Dr.Ste 4 - 4666
Wilmington DE 19804
U.S.:- + 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707